Possible Bearish Signals With Boston Scientific Insiders Disposing Stock

In This Article:

Many Boston Scientific Corporation (NYSE:BSX) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Boston Scientific Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the Lead Independent Director, Edward Ludwig, for US$1.3m worth of shares, at about US$105 per share. So we know that an insider sold shares at around the present share price of US$103. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

In total, Boston Scientific insiders sold more than they bought over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

View our latest analysis for Boston Scientific

insider-trading-volume
NYSE:BSX Insider Trading Volume May 10th 2025

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Boston Scientific Insiders Are Selling The Stock

The last three months saw significant insider selling at Boston Scientific. In total, Lead Independent Director Edward Ludwig dumped US$1.3m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

Does Boston Scientific Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that Boston Scientific insiders own 0.2% of the company, worth about US$281m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.